Raymond James & Associates’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$217K	Sell	14,119 -333	-2%	-$5.55K	﹤0.01%	3595
2024 Q2	$235K	Buy	14,452 +1,643	+13%	+$26.5K	﹤0.01%	3518
2024 Q1	$237K	Buy	+12,809	New	+$317K	﹤0.01%	3524
2023 Q4	–	Sell	-10,614	Closed	-$221K	–	3827
2023 Q3	$221K	Buy	10,614 +1,630	+18%	+$44.3K	﹤0.01%	3400
2023 Q2	$215K	Buy	+8,984	New	+$200K	﹤0.01%	3441
2021 Q1	–	Sell	-31,372	Closed	-$1.68M	–	3988
2020 Q4	$1.68M	Buy	+31,372	New	+$1.56M	﹤0.01%	2001
2020 Q3	–	Sell	-17,073	Closed	-$828K	–	3582
2020 Q2	$828K	Sell	17,073 -2,307	-12%	-$111K	﹤0.01%	2282
2020 Q1	$819K	Sell	19,380 -2,390	-11%	-$98.5K	﹤0.01%	2112
2019 Q4	$931K	Buy	21,770 +7,672	+54%	+$334K	﹤0.01%	2307
2019 Q3	$507K	Sell	14,098 -633	-4%	-$19.2K	﹤0.01%	2637
2019 Q2	$394K	Buy	+14,731	New	+$376K	﹤0.01%	2830
2017 Q1	–	Sell	-16,289	Closed	-$470K	–	3292
2016 Q4	$470K	Buy	16,289 +1,896	+13%	+$50.2K	﹤0.01%	2371
2016 Q3	$458K	Buy	14,393 +5,749	+67%	+$195K	﹤0.01%	2341
2016 Q2	$281K	Buy	8,644 +440	+5%	+$14.7K	﹤0.01%	2443
2016 Q1	$229K	Sell	8,204 -51,347	-86%	-$1.12M	﹤0.01%	2502
2015 Q4	$2.12M	Buy	59,551 +2,744	+5%	+$96.7K	0.01%	1232
2015 Q3	$1.88M	Buy	56,807 +6,636	+13%	+$276K	0.01%	1250
2015 Q2	$2.1M	Buy	50,171 +2,295	+5%	+$88.8K	0.01%	1288
2015 Q1	$1.56M	Sell	47,876 -4,225	-8%	-$145K	0.01%	1392
2014 Q4	$1.65M	Buy	+52,101	New	+$1.48M	0.01%	1272